Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

75%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (25.0%)

N/A3 (75.0%)

Trials by Status

terminated125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS)

NCT01439958

Clinical Trials (4)

Showing 4 of 4 trials

NCT03722771Not Applicable

Influence of Lavender Oil on Vital Signs in Oral Surgery Patients

Completed

NCT04115891Not Applicable

Lavender Oil Inhalation Help to Overcome Dental Anxiety Among Children

Completed

NCT03524066Not Applicable

Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)

Completed

NCT01439958Phase 3

Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS)

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4